To determine any significant differences in hematological effects for DDS between G6PD normal and deficient individuals would require a large study to evaluate rare events in this subpopulation; approximately 2500−10,000 patients depending on the prevalence of G6PD deficiency. The gene discussed is G6PD; the disease is hyperinsulinemic hypoglycemia, familial, 4.